Targeting Autoantigens to Overcome Allogeneic Treg Rejection & Enhance Therapeutic Success
- Discussing interactions between the immune system and allogeneic Tregs to identify rejection mechanisms
- Investigating opportunities to define and target autoantigens key to allogeneic Treg rejection
- Strategies to remove or modify autoantigens to enhance persistence and prevent treatment rejection